Indian J Pharm Close
 

Table 2: Severity and relatedness of treatment-emergent adverse events (occurred in >1% patients by System Organ Class and Preferred Terms)

Table 2: Severity and relatedness of treatment-emergent adverse events (occurred in >1% patients by System Organ Class and Preferred Terms)